182 related articles for article (PubMed ID: 11763313)
1. Chromosome 9 alterations and trisomy 22 in central chondrosarcoma: a cytogenetic and DNA flow cytometric analysis of chondrosarcoma subtypes.
Bovée JV; Sciot R; Dal Cin P; Debiec-Rychter M; van Zelderen-Bhola SL; Cornelisse CJ; Hogendoorn PC
Diagn Mol Pathol; 2001 Dec; 10(4):228-35. PubMed ID: 11763313
[TBL] [Abstract][Full Text] [Related]
2. Loss of heterozygosity and DNA ploidy point to a diverging genetic mechanism in the origin of peripheral and central chondrosarcoma.
Bovée JV; Cleton-Jansen AM; Kuipers-Dijkshoorn NJ; van den Broek LJ; Taminiau AH; Cornelisse CJ; Hogendoorn PC
Genes Chromosomes Cancer; 1999 Nov; 26(3):237-46. PubMed ID: 10502322
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of cytofluorometric DNA ploidy analysis in distinguishing benign cartilaginous tumors from chondrosarcomas.
Kusuzaki K; Murata H; Takeshita H; Hirata M; Hashiguchi S; Tsuji Y; Nakamura S; Ashihara T; Hirasawa Y
Mod Pathol; 1999 Sep; 12(9):863-72. PubMed ID: 10496594
[TBL] [Abstract][Full Text] [Related]
4. [Comparative DNA cytometric and cytogenetic ploidy determination of chondrosarcoma and osteosarcoma].
Werner M; Rieck J; Heintz A; Pösl M; Delling G
Pathologe; 1996 Sep; 17(5):374-9. PubMed ID: 8992480
[TBL] [Abstract][Full Text] [Related]
5. A common cytogenetic abnormality and DNA content alterations in dedifferentiated chondrosarcoma.
Zalupski MM; Ensley JF; Ryan J; Selvaggi S; Baker LH; Wolman SR
Cancer; 1990 Sep; 66(6):1176-82. PubMed ID: 2400969
[TBL] [Abstract][Full Text] [Related]
6. Molecular analysis of the INK4A/INK4A-ARF gene locus in conventional (central) chondrosarcomas and enchondromas: indication of an important gene for tumour progression.
van Beerendonk HM; Rozeman LB; Taminiau AH; Sciot R; Bovée JV; Cleton-Jansen AM; Hogendoorn PC
J Pathol; 2004 Mar; 202(3):359-66. PubMed ID: 14991902
[TBL] [Abstract][Full Text] [Related]
7. Cytogenetics as a tool in the histologic subclassification of chondrosarcomas.
Dijkhuizen T; van den Berg E; Molenaar WM; Oosterhuis JW; Dam A; Wiersema J; Schraffordt Koops H; de Jong B
Cancer Genet Cytogenet; 1994 Sep; 76(2):100-5. PubMed ID: 7923056
[TBL] [Abstract][Full Text] [Related]
8. Near-haploidy and subsequent polyploidization characterize the progression of peripheral chondrosarcoma.
Bovée JV; van Royen M; Bardoel AF; Rosenberg C; Cornelisse CJ; Cleton-Jansen AM; Hogendoorn PC
Am J Pathol; 2000 Nov; 157(5):1587-95. PubMed ID: 11073818
[TBL] [Abstract][Full Text] [Related]
9. Secondary peripheral chondrosarcoma evolving from osteochondroma as a result of outgrowth of cells with functional EXT.
de Andrea CE; Reijnders CM; Kroon HM; de Jong D; Hogendoorn PC; Szuhai K; Bovée JV
Oncogene; 2012 Mar; 31(9):1095-104. PubMed ID: 21804604
[TBL] [Abstract][Full Text] [Related]
10. Rb-loss is associated with high malignancy in chondrosarcoma.
Röpke M; Boltze C; Meyer B; Neumann HW; Roessner A; Schneider-Stock R
Oncol Rep; 2006 Jan; 15(1):89-95. PubMed ID: 16328039
[TBL] [Abstract][Full Text] [Related]
11. DNA flow cytometric analysis of chest-wall chondroma and chondrosarcoma.
Shih CS; Wang LS; Yang SS; Fahn HJ; Wu LH; Chen WY; Huang MH
Scand J Thorac Cardiovasc Surg; 1996; 30(3-4):157-61. PubMed ID: 8976036
[TBL] [Abstract][Full Text] [Related]
12. Chromosome 9 related aberrations and deletions of the CDKN2 and MTS2 putative tumor suppressor genes in human chondrosarcomas.
Jagasia AA; Block JA; Qureshi A; Diaz MO; Nobori T; Gitelis S; Iyer AP
Cancer Lett; 1996 Jul; 105(1):91-103. PubMed ID: 8689637
[TBL] [Abstract][Full Text] [Related]
13. H3K27me3 deficiency defines a subset of dedifferentiated chondrosarcomas with characteristic clinicopathological features.
Makise N; Sekimizu M; Konishi E; Motoi T; Kubo T; Ikoma H; Watanabe SI; Okuma T; Hiraoka N; Fukayama M; Kawai A; Ichikawa H; Yoshida A
Mod Pathol; 2019 Mar; 32(3):435-445. PubMed ID: 30291346
[TBL] [Abstract][Full Text] [Related]
14. Molecular genetic characterization of both components of a dedifferentiated chondrosarcoma, with implications for its histogenesis.
Bovée JV; Cleton-Jansen AM; Rosenberg C; Taminiau AH; Cornelisse CJ; Hogendoorn PC
J Pathol; 1999 Dec; 189(4):454-62. PubMed ID: 10629543
[TBL] [Abstract][Full Text] [Related]
15. Aberrant heparan sulfate proteoglycan localization, despite normal exostosin, in central chondrosarcoma.
Schrage YM; Hameetman L; Szuhai K; Cleton-Jansen AM; Taminiau AH; Hogendoorn PC; Bovée JV
Am J Pathol; 2009 Mar; 174(3):979-88. PubMed ID: 19179614
[TBL] [Abstract][Full Text] [Related]
16. Cytogenetic aberrations and their prognostic impact in chondrosarcoma.
Mandahl N; Gustafson P; Mertens F; Akerman M; Baldetorp B; Gisselsson D; Knuutila S; Bauer HC; Larsson O
Genes Chromosomes Cancer; 2002 Feb; 33(2):188-200. PubMed ID: 11793445
[TBL] [Abstract][Full Text] [Related]
17. Correlation between clinicopathological features and karyotype in 100 cartilaginous and chordoid tumours. A report from the Chromosomes and Morphology (CHAMP) Collaborative Study Group.
Tallini G; Dorfman H; Brys P; Dal Cin P; De Wever I; Fletcher CD; Jonson K; Mandahl N; Mertens F; Mitelman F; Rosai J; Rydholm A; Samson I; Sciot R; Van den Berghe H; Vanni R; Willén H
J Pathol; 2002 Feb; 196(2):194-203. PubMed ID: 11793371
[TBL] [Abstract][Full Text] [Related]
18. [Pathomorphology of malignant chondrogenic bone tumors--an analysis of 94 cases from the Hamburg Bone Tumor Register (1974-1989)].
Delling G; Welkerling H
Z Orthop Ihre Grenzgeb; 1992; 130(1):1-8. PubMed ID: 1532267
[TBL] [Abstract][Full Text] [Related]
19. Array-comparative genomic hybridization of central chondrosarcoma: identification of ribosomal protein S6 and cyclin-dependent kinase 4 as candidate target genes for genomic aberrations.
Rozeman LB; Szuhai K; Schrage YM; Rosenberg C; Tanke HJ; Taminiau AH; Cleton-Jansen AM; Bovée JV; Hogendoorn PC
Cancer; 2006 Jul; 107(2):380-8. PubMed ID: 16779802
[TBL] [Abstract][Full Text] [Related]
20. Loss of heterozygosity and tumor suppressor gene mutations in chondrosarcomas.
Yamaguchi T; Toguchida J; Wadayama B; Kanoe H; Nakayama T; Ishizaki K; Ikenaga M; Kotoura Y; Sasaki MS
Anticancer Res; 1996; 16(4A):2009-15. PubMed ID: 8712735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]